Clinical trials recruiting in Mandaluyong, Philippines
3
Recruiting trials
8
Conditions
Phase breakdown
Phase 3 2Not applicable 1
Conditions recruiting in Mandaluyong, Philippines
| Condition | Trials |
|---|---|
| Chronic Kidney Disease | 2 |
| Atherosclerosis Cardiovascular Disease | 1 |
| HIV | 1 |
| HIV Pre-Exposure Prophylaxis | 1 |
| Heart Failure | 1 |
| Human Immunodeficiency Virus (HIV) | 1 |
| Hypertension | 1 |
| Type 2 Diabetes | 1 |
Recruiting trials in Mandaluyong, Philippines
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Common questions
How many clinical trials are recruiting in Mandaluyong, Philippines?
3 recruiting trials have at least one study site in Mandaluyong, Philippines.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.